LUMICKS

LUMICKS is a leading provider of dynamic single-molecule and cell avidity analysis instruments, aiming to empower scientists with tools that reveal crucial insights at the molecular and cellular level. Leveraging innovative and Nobel Prize-winning technologies, such as optical tweezers and STED super-resolution, the company's instruments enable the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells, contributing to a deeper understanding of life at its smallest scale. Founded in 2014, LUMICKS operates within the Biotechnology, Life Sciences, and Medical Devices industries, with its headquarters located in The Netherlands. The company's latest investment, a Debt Financing round, was secured on 10th October 2024. Despite the absence of specific investor details, this investment signifies confidence in LUMICKS' innovative solutions. The company's focus on advancing science and improving human health by providing tools that unlock the measurement of forces and interactions in biology demonstrates its commitment to making meaningful contributions to the field. By directly linking structural and ‘omics analysis to functional outcomes at both a molecular and cellular level, LUMICKS' unparalleled solutions offer the potential to revolutionize research by enabling detailed real-time analysis of underlying biological mechanisms.